ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,810,000 | +155.9% | 202,032 | +59.7% | 0.00% | +100.0% |
| Q2 2019 | $1,489,000 | +558.8% | 126,526 | +663.8% | 0.00% | – |
| Q1 2019 | $226,000 | -74.8% | 16,565 | -81.1% | 0.00% | -100.0% |
| Q4 2018 | $896,000 | -26.5% | 87,479 | +19.5% | 0.00% | 0.0% |
| Q3 2018 | $1,219,000 | +124.1% | 73,228 | +112.4% | 0.00% | – |
| Q2 2018 | $544,000 | +19.0% | 34,475 | -4.1% | 0.00% | – |
| Q1 2018 | $457,000 | +196.8% | 35,952 | +168.2% | 0.00% | – |
| Q4 2017 | $154,000 | -91.5% | 13,407 | -91.0% | 0.00% | -100.0% |
| Q3 2017 | $1,821,000 | +1114.0% | 148,656 | +1029.1% | 0.00% | – |
| Q2 2017 | $150,000 | -63.3% | 13,166 | -33.0% | 0.00% | – |
| Q1 2017 | $409,000 | -65.9% | 19,643 | -65.9% | 0.00% | -100.0% |
| Q4 2016 | $1,198,000 | +1202.2% | 57,557 | +1954.1% | 0.00% | – |
| Q3 2016 | $92,000 | +360.0% | 2,802 | +245.9% | 0.00% | – |
| Q2 2016 | $20,000 | -99.7% | 810 | -99.7% | 0.00% | -100.0% |
| Q1 2016 | $6,336,000 | +112.3% | 263,991 | +191.8% | 0.01% | +150.0% |
| Q4 2015 | $2,985,000 | +687.6% | 90,472 | +665.0% | 0.00% | – |
| Q3 2015 | $379,000 | +1622.7% | 11,827 | +2791.7% | 0.00% | – |
| Q2 2015 | $22,000 | -15.4% | 409 | -56.9% | 0.00% | – |
| Q1 2015 | $26,000 | +36.8% | 949 | +46.0% | 0.00% | – |
| Q4 2014 | $19,000 | +5.6% | 650 | -58.1% | 0.00% | – |
| Q3 2014 | $18,000 | +350.0% | 1,550 | +780.7% | 0.00% | – |
| Q2 2014 | $4,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |